Erdafitinib Currently Not FDA-Approved | Granted Breakthrough Designation Therapy
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Erdafitinib Currently Not FDA-Approved | Granted Breakthrough Designation Therapy at ASCO 2018
Author: Annual-Meeting
Added: 06/21/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts